What Researchers Did
Researchers compared outcomes for 62 patients with Fournier's gangrene who either received hyperbaric oxygen therapy or did not, alongside their standard medical and surgical treatments.
What They Found
This retrospective study found that patients receiving hyperbaric oxygen therapy (HBO) had more severe initial conditions, including higher C-reactive protein and urea levels, and 100% met sepsis criteria compared to 77.8% in the non-HBO group. The HBO group also experienced longer average intensive care unit stays (32 vs. 9 days) and more debridement surgeries (13 vs. 5). However, mortality was 0% in the HBO group compared to 4.4% in patients who did not receive HBO.
What This Means for Canadian Patients
For Canadian patients diagnosed with Fournier's gangrene, a serious and rapidly progressing infection, this study suggests that hyperbaric oxygen therapy, when added to standard care, may be associated with a lower risk of death. Although patients receiving HBO in this study appeared to be sicker initially and required longer hospital stays, their survival rate was higher.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a retrospective observational study with a small number of patients in the hyperbaric oxygen group, and patients receiving HBO appeared to have more severe initial conditions.